Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis (Q45883065)

17 December 2017

http://europepmc.org/abstract/MED/11821939

title

Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis (English)

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

author name string

Guéry L

1

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

Chiocchia G

2

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

Batteux F

3

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

Boissier MC

4

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

Fournier C

5

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

publication date

1 December 2001

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

published in

Gene Therapy

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

volume

8

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

issue

24

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

page(s)

1855-1862

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

cites work

Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Specific immunotherapy by genetically engineered APCs: the "guided missile" strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Antigen presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Regulatory T cells: key controllers of immunologic self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Interleukin-10 inhibition of the progression of established collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Immunisation against heterologous type II collagen induces arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

Biphasic effect of interferon-gamma in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen‐induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Selective increased presentation of type II collagen by leupeptin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Arthritogenicity of minor cartilage collagens (types IX and XI) in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Arthritis-associated changes in flow cytometric characteristics of cultured synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301613

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301613

1 reference

17 December 2017

http://europepmc.org/abstract/MED/11821939

Dimensions Publication ID

1012572521

0 references

1 reference

17 December 2017